Cohance Lifesciences Ltd. manufactures chemical products. It specializes in providing pharmaceutical solutions to global life science companies. The firm engages in Contract Research & Manufacturing Services (CRMS) business where research and development is customized to the needs of global pharmaceutical customers. Its business segments include pharmaceutical solutions, active pharma ingredients, intermediates and formulations. The company was founded on November 6, 2018 and is headquartered in Hyderabad, Telangana.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2,295
Frequently Asked Questions
What is Market Cap of Cohance Lifesciences Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Cohance Lifesciences Ltd market cap is 115.5B.
What is the 52-week high for Cohance Lifesciences Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cohance Lifesciences Ltd 52 week high is 1,250.00 as of April 02, 2026.
What is the 52-week low for Cohance Lifesciences Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cohance Lifesciences Ltd 52 week low is 266.70 as of April 02, 2026.
What is Cohance Lifesciences Ltd stock price today?
Cohance Lifesciences Ltd stock price today is 312.00.
What was Cohance Lifesciences Ltd stock price yesterday?
Cohance Lifesciences Ltd stock price yesterday was 302.85.
What is the PE ratio of Cohance Lifesciences Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Cohance Lifesciences Ltd's P/E ratio is 53.54.
What is the Price-to-Book ratio of Cohance Lifesciences Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Cohance Lifesciences Ltd P/B ratio is 3.1507.
What is the 50-day moving average of Cohance Lifesciences Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Cohance Lifesciences Ltd 50-day moving average is 329.09.
How many employees does Cohance Lifesciences Ltd have?